COVID-19 Vaccines Found to Be Beneficial for Cancer Patients

 

 

Research suggests that mRNA COVID-19 vaccines may offer unexpected benefits to cancer patients. A study published in the journal *Nature* indicates that patients with lung or skin cancer—who are undergoing immunotherapy—tend to have better survival outcomes if they receive a Pfizer or Moderna COVID-19 vaccine within 100 days of starting their treatment.

The research team is now conducting further studies to explore the potential of treatment regimens that combine these mRNA COVID-19 vaccines with cancer therapies.